Abstract The coronavirus disease 2019 (COVID-19) pandemic has compelled biomedical researchers to communicate data in real time to establish more effective medical treatments and public health policies. Nontraditional sources such as preprint publications, i.e. articles not yet validated by peer review, have become crucial hubs for the dissemination of scientific results. Natural language processing (NLP) systems have been recently developed to extract and organize COVID-19 data in reasoning systems. Given this scenario, the BioCreative COVID-19 text mining tool interactive demonstration track was created to assess the landscape of the available tools and to gauge user interest, thereby providing a two-way communication channel between NLP system developers and potential end users. The goal was to inform system designers about the performance and usability of their products and to suggest new additional features. Considering the exploratory nature of this track, the call for participation solicited teams to apply for the track, based on their system’s ability to perform COVID-19-related tasks and interest in receiving user feedback. We also recruited volunteer users to test systems. Seven teams registered systems for the track, and >30 individuals volunteered as test users; these volunteer users covered a broad range of specialties, including bench scientists, bioinformaticians and biocurators. The users, who had the option to participate anonymously, were provided with written and video documentation to familiarize themselves with the NLP tools and completed a survey to record their evaluation. Additional feedback was also provided by NLP system developers. The track was well received as shown by the overall positive feedback from the participating teams and the users. Database URL: https://biocreative.bioinformatics.udel.edu/tasks/biocreative-vii/track-4/

Monitoring drug safety is a central concern throughout the drug life cycle. Information about toxicity and adverse events is generated at every stage of this life cycle, and stakeholders have a strong interest in applying text mining and artificial intelligence (AI) methods to manage the ever-increasing volume of this information. Recognizing the importance of these applications and the role of challenge evaluations to drive progress in text mining, the organizers of BioCreative VII (Critical Assessment of Information Extraction in Biology) convened a panel of experts to explore 'Challenges in Mining Drug Adverse Reactions'. This article is an outgrowth of the panel; each panelist has highlighted specific text mining application(s), based on their research and their experiences in organizing text mining challenge evaluations. While these highlighted applications only sample the complexity of this problem space, they reveal both opportunities and challenges for text mining to aid in the complex process of drug discovery, testing, marketing and post-market surveillance. Stakeholders are eager to embrace natural language processing and AI tools to help in this process, provided that these tools can be demonstrated to add value to stakeholder workflows. This creates an opportunity for the BioCreative community to work in partnership with regulatory agencies, pharma and the text mining community to identify next steps for future challenge evaluations.

This report presents the evaluation approach developed for the DARPA Big Mechanism program, which aimed at developing computer systems that will read research papers, integrate the information into a computer model of cancer mechanisms, and frame new hypotheses. We employed an iterative, incremental approach to the evaluation of the three phases of the program. In Phase I, we evaluated the ability of system and human teams ability to read-with-a-model to capture mechanistic information from the biomedical literature, integrated with information from expert curated biological databases. In Phase II we evaluated the ability of systems to assemble fragments of information into a mechanistic model. The Phase III evaluation focused on the ability of systems to provide explanations of experimental observations based on models assembled (largely automatically) by the Big Mechanism process. The evaluation for each phase built on earlier evaluations and guided developers towards creating capabilities for the new phase. The report describes our approach, including innovations such as a reference set (a curated data set limited to major findings of each paper) to assess the accuracy of systems in extracting mechanistic findings in the absence of a gold standard, and a method to evaluate model-based explanations of experimental data. Results of the evaluation and supporting materials are included in the appendices.

There is a growing desire to create computer systems that can collaborate with humans on complex, open-ended activities. These activities typically have no set completion criteria and frequently involve multimodal communication, extensive world knowledge, creativity, and building structures or compositions through multiple steps. Because these systems differ from question and answer (Q&A) systems, chatbots, and simple task-oriented assistants, new methods for evaluating such collaborative computer systems are needed. Here, we present a set of criteria for evaluating these systems, called Hallmarks of Human-Machine Collaboration . The Hallmarks build on the success of heuristic evaluation used by the user interface community and past evaluation techniques used in the spoken language and chatbot communities. They consist of observable characteristics indicative of successful collaborative communication, grouped into eight high-level properties: robustness; habitability; mutual contribution of meaningful content; context-awareness; consistent human engagement; provision of rationale; use of elementary concepts to teach and learn new concepts; and successful collaboration. We present examples of how we used these Hallmarks in the DARPA Communicating with Computers (CwC) program to evaluate diverse activities, including story and music generation, interactive building with blocks, and exploration of molecular mechanisms in cancer. We used the Hallmarks as guides for developers and as diagnostics, assessing systems with the Hallmarks to identify strengths and opportunities for improvement using logs from user studies, surveying the human partner, third-party review of creative products, and direct tests. Informal feedback from CwC technology developers indicates that the use of the Hallmarks for program evaluation helped guide development. The Hallmarks also made it possible to identify areas of progress and major gaps in developing systems where the machine is an equal, creative partner.

As the pace of COVID-19 research rapidly escalated during the pandemic, we built a platform to help biomedical experts easily discover published research about potential COVID-19 therapeutics and vaccines. The platform, COVID-TIB for short, uses rule-based natural language processing to identify documents about viruses, drugs, and vaccine types at scale. COVID-TIB displays numbers of journal papers, preprints, and clinical trials about particular drugs and SARS-CoV-2 and other viruses, binned by research stage. Users can apply multiple filters (e.g., recency, publication type, virus) to winnow results, select a set to see document metadata with links, and download search results. Users can also search for terms in the full text of papers and filter papers based on these search terms. In addition, users can link out to xDD’s COSMOS system (https://xdd.wisc.edu/set_visualizer/sets/xdd-covid-19) to browse figures and tables related to a virus and therapeutic. COVID-TIB currently presents information on 13 viruses and nearly 3,000 therapeutics found in 26K paper abstracts and clinical trial summaries. COVID-TIB can be used to browse recent drug research, identify promising drug candidates, gather information for reviews and meta-analyses, and track research over time. COVID-TIB is available at https://covidtib.c19hcc.org/. Keywords—COVID-19, therapeutics, drugs, natural language processing, text mining

There is a growing desire to create computer systems that can communicate effectively to collaborate with humans on complex, open-ended activities. Assessing these systems presents significant challenges. We describe a framework for evaluating systems engaged in open-ended complex scenarios where evaluators do not have the luxury of comparing performance to a single right answer. This framework has been used to evaluate human-machine creative collaborations across story and music generation, interactive block building, and exploration of molecular mechanisms in cancer. These activities are fundamentally different from the more constrained tasks performed by most contemporary personal assistants as they are generally open-ended, with no single correct solution, and often no obvious completion criteria. We identified the Key Properties that must be exhibited by successful systems. From there we identified"Hallmarks"of success -- capabilities and features that evaluators can observe that would be indicative of progress toward achieving a Key Property. In addition to being a framework for assessment, the Key Properties and Hallmarks are intended to serve as goals in guiding research direction.

OBJECTIVEEffective, scalable de-identification of personally identifying information (PII) for information-rich clinical text is critical to support secondary use, but no method is 100% effective. The hiding-in-plain-sight (HIPS) approach attempts to solve this "residual PII problem." HIPS replaces PII tagged by a de-identification system with realistic but fictitious (resynthesized) content, making it harder to detect remaining unredacted PII.MATERIALS AND METHODSUsing 2000 representative clinical documents from 2 healthcare settings (4000 total), we used a novel method to generate 2 de-identified 100-document corpora (200 documents total) in which PII tagged by a typical automated machine-learned tagger was replaced by HIPS-resynthesized content. Four readers conducted aggressive reidentification attacks to isolate leaked PII: 2 readers from within the originating institution and 2 external readers.RESULTSOverall, mean recall of leaked PII was 26.8% and mean precision was 37.2%. Mean recall was 9% (mean precision = 37%) for patient ages, 32% (mean precision = 26%) for dates, 25% (mean precision = 37%) for doctor names, 45% (mean precision = 55%) for organization names, and 23% (mean precision = 57%) for patient names. Recall was 32% (precision = 40%) for internal and 22% (precision =33%) for external readers.DISCUSSION AND CONCLUSIONSApproximately 70% of leaked PII "hiding" in a corpus de-identified with HIPS resynthesis is resilient to detection by human readers in a realistic, aggressive reidentification attack scenario-more than double the rate reported in previous studies but less than the rate reported for an attack assisted by machine learning methods.

The US FDA is interested in a tool that would enable pharmacovigilance safety evaluators to automate the identification of adverse drug events (ADEs) mentioned in FDA prescribing information. The MITRE Corporation (MITRE) and the FDA organized a shared task—Adverse Drug Event Evaluation (ADE Eval)—to determine whether the performance of algorithms currently used for natural language processing (NLP) might be good enough for real-world use. ADE Eval was conducted to evaluate a range of NLP techniques for identifying ADEs mentioned in publicly available FDA-approved drug labels (package inserts). It was designed specifically to reflect pharmacovigilance practices within the FDA and model possible pharmacovigilance use cases. Pharmacovigilance-specific annotation guidelines and annotated corpora were created. Two metrics modeled the experiences of FDA safety evaluators: one measured the ability of an algorithm to identify correct Medical Dictionary for Regulatory Activities (MedDRA®) terms for the text from the annotated corpora, and the other assessed the quality of evidence extracted from the corpora to support the selected MedDRA® term by measuring the portion of annotated text an algorithm correctly identified. A third metric assessed the cost of correcting system output for subsequent training (averaged, weighted F1-measure for mention finding). In total, 13 teams submitted 23 runs: the top MedDRA® coding F1-measure was 0.79, the top quality score was 0.96, and the top mention-finding F1-measure was 0.89. While NLP techniques do not perform at levels that would allow them to be used without intervention, it is now worthwhile exploring making NLP outputs available in human pharmacovigilance workflows.

Forecasting is beginning to be integrated into decision-making processes for infectious disease outbreak response. We discuss how technologies could accelerate the adoption of forecasting among public health practitioners, improve epidemic management, save lives, and reduce the economic impact of outbreaks.

Objective: Clinical corpora can be deidentified using a combination of machine-learned automated taggers and hiding in plain sight (HIPS) resynthesis. The latter replaces detected personally identifiable information (PII) with random surrogates, allowing leaked PII to blend in or "hide in plain sight." We evaluated the extent to which a malicious attacker could expose leaked PII in such a corpus. Materials and Methods: We modeled a scenario where an institution (the defender) externally shared an 800-note corpus of actual outpatient clinical encounter notes from a large, integrated health care delivery system in Washington State. These notes were deidentified by a machine-learned PII tagger and HIPS resynthesis. A malicious attacker obtained and performed a parrot attack intending to expose leaked PII in this corpus. Specifically, the attacker mimicked the defender's process by manually annotating all PII-like content in half of the released corpus, training a PII tagger on these data, and using the trained model to tag the remaining encounter notes. The attacker hypothesized that untagged identifiers would be leaked PII, discoverable by manual review. We evaluated the attacker's success using measures of leak-detection rate and accuracy. Results: The attacker correctly hypothesized that 211 (68%) of 310 actual PII leaks in the corpus were leaks, and wrongly hypothesized that 191 resynthesized PII instances were also leaks. One-third of actual leaks remained undetected. Discussion and Conclusion: A malicious parrot attack to reveal leaked PII in clinical text deidentified by machine-learned HIPS resynthesis can attenuate but not eliminate the protective effect of HIPS deidentification.

OBJECTIVE:Our objective was to develop a machine learning-based system to determine the severity of Positive Valance symptoms for a patient, based on information included in their initial psychiatric evaluation. Severity was rated on an ordinal scale of 0-3 as follows: 0 (absent=no symptoms), 1 (mild=modest significance), 2 (moderate=requires treatment), 3 (severe=causes substantial impairment) by experts. MATERIALS AND METHODS:We treated the task of assigning Positive Valence severity as a text classification problem. During development, we experimented with regularized multinomial logistic regression classifiers, gradient boosted trees, and feedforward, fully-connected neural networks. We found both regularization and feature selection via mutual information to be very important in preventing models from overfitting the data. Our best configuration was a neural network with three fully connected hidden layers with rectified linear unit activations. RESULTS:Our best performing system achieved a score of 77.86%. The evaluation metric is an inverse normalization of the Mean Absolute Error presented as a percentage number between 0 and 100, where 100 means the highest performance. Error analysis showed that 90% of the system errors involved neighboring severity categories. CONCLUSION:Machine learning text classification techniques with feature selection can be trained to recognize broad differences in Positive Valence symptom severity with a modest amount of training data (in this case 600 documents, 167 of which were unannotated). An increase in the amount of annotated data can increase accuracy of symptom severity classification by several percentage points. Additional features and/or a larger training corpus may further improve accuracy.

Fully automated text mining (TM) systems promote efficient literature searching, retrieval, and review but are not sufficient to produce ready-to-consume curated documents. These systems are not meant to replace biocurators, but instead to assist them in one or more literature curation steps. To do so, the user interface is an important aspect that needs to be considered for tool adoption. The BioCreative Interactive task (IAT) is a track designed for exploring user-system interactions, promoting development of useful TM tools, and providing a communication channel between the biocuration and the TM communities. In BioCreative V, the IAT track followed a format similar to previous interactive tracks, where the utility and usability of TM tools, as well as the generation of use cases, have been the focal points. The proposed curation tasks are user-centric and formally evaluated by biocurators. In BioCreative V IAT, seven TM systems and 43 biocurators participated. Two levels of user participation were offered to broaden curator involvement and obtain more feedback on usability aspects. The full level participation involved training on the system, curation of a set of documents with and without TM assistance, tracking of time-on-task, and completion of a user survey. The partial level participation was designed to focus on usability aspects of the interface and not the performance per se. In this case, biocurators navigated the system by performing pre-designed tasks and then were asked whether they were able to achieve the task and the level of difficulty in completing the task. In this manuscript, we describe the development of the interactive task, from planning to execution and discuss major findings for the systems tested. Database URL: http://www.biocreative.org

Crowdsourcing is increasingly utilized for performing tasks in both natural language processing and biocuration. Although there have been many applications of crowdsourcing in these fields, there have been fewer high-level discussions of the methodology and its applicability to biocuration. This paper explores crowdsourcing for biocuration through several case studies that highlight different ways of leveraging 'the crowd'; these raise issues about the kind(s) of expertise needed, the motivations of participants, and questions related to feasibility, cost and quality. The paper is an outgrowth of a panel session held at BioCreative V (Seville, September 9-11, 2015). The session consisted of four short talks, followed by a discussion. In their talks, the panelists explored the role of expertise and the potential to improve crowd performance by training; the challenge of decomposing tasks to make them amenable to crowdsourcing; and the capture of biological data and metadata through community editing.

Objective: Electronic medical records (EMRs) are increasingly repurposed for activities beyond clinical care, such as to support translational research and public policy analysis. To mitigate privacy risks, healthcare organizations (HCOs) aim to remove potentially identifying patient information. A substantial quantity of EMR data is in natural language form and there are concerns that automated tools for detecting identifiers are imperfect and leak information that can be exploited by ill-intentioned data recipients. Thus, HCOs have been encouraged to invest as much effort as possible to find and detect potential identifiers, but such a strategy assumes the recipients are sufficiently incentivized and capable of exploiting leaked identifiers. In practice, such an assumption may not hold true and HCOs may overinvest in de identification technology. The goal of this study is to design a natural language de-identification framework, rooted in game theory, which enables an HCO to optimize their investments given the expected capabilities of an adversarial recipient.Methods: We introduce a Stackelberg game to balance risk and utility in natural language de identification. This game represents a cost-benefit model that enables an HCO with a fixed budget to minimize their investment in the de-identification process. We evaluate this model by assessing the overall payoff to the HCO and the adversary using 2100 clinical notes from Vanderbilt University Medical Center. We simulate several policy alternatives using a range of parameters, including the cost of training a de identification model and the loss in data utility due to the removal of terms that are not identifiers. In addition, we compare policy options where, when an attacker is fined for misuse, a monetary penalty is paid to the publishing HCO as opposed to a third party (e.g., a federal regulator).Results: Our results show that when an HCO is forced to exhaust a limited budget (set to $2000 in the study), the precision and recall of the de-identification of the HCO are 0.86 and 0.8, respectively. A game-based approach enables a more refined cost-benefit tradeoff, improving both privacy and utility for the HCO. For example, our investigation shows that it is possible for an HCO to release the data without spending all their budget on de-identification and still deter the attacker, with a precision of 0.77 and a recall of 0.61 for the de-identification. There also exist scenarios in which the model indicates an HCO should not release any data because the risk is too great. In addition, we find that the practice of paying fines back to a HCO (an artifact of suing for breach of contract), as opposed to a third party such as a federal regulator, can induce an elevated level of data sharing risk, where the HCO is incentivized to bait the attacker to elicit compensation.Conclusions: A game theoretic framework can be applied in leading HCO's to optimized decision making in natural language de-identification investments before sharing EMR data. (C) 2016 Elsevier Inc. All rights reserved.